• generic Harvoni - Ledviclear

generic Harvoni - Ledviclear

  • Ledipasvir 90 mg and sofosbuvir 400 mg
  • Harvoni
  • 90mg/400mg
  • Abbott

Ledviclear (ledipasvir 90 mg/sofosbuvir 400 mg) tablets is manufactured by Abbott.

Ledviclear (ledipasvir 90 mg/sofosbuvir 400 mg) is a generic of Harvoni of Gilead

Ledviclear (ledipasvir 90 mg/sofosbuvir 400 mg) tablets available in bottle of 28 tablets.

Ledviclear (ledipasvir 90 mg/sofosbuvir 400 mg) tablets is indicated for the treatment of chronic hepatitis C (CHC) in adults.

Ledviclear generic Harvoni (Ledipasvir 90 mg/sofosbuvir 400 mg) of Abbott available in bottle of 28 tablets. Ledviclear generic Harvoni (Ledipasvir 90 mg/sofosbuvir 400 mg) is known as a nucleotide polymerase inhibitor, and it works directly on the virus itself. Ledviclear generic Harvoni (Ledipasvir 90 mg/sofosbuvir 400 mg) of Abbott, mechanism of action involves inhibiting the enzyme which is necessary for the virus if it is to multiply. Precautions Patients who are undergoing treatment for Hepatitis C with Ledviclear generic Harvoni (Ledipasvir 90 mg/sofosbuvir 400 mg) will require regular visits to their physician or the hospital so that routine blood tests can be carried out. Adult patients will usually be directed by their physician to take 1 tablet of Ledviclear generic Harvoni (Ledipasvir 90 mg/sofosbuvir 400 mg) per day, and it can be administered alongside a meal or else without food. The frequency at which these tests are required will be determined by your physician. The dosage of Ledviclear generic Harvoni (Ledipasvir 90 mg/sofosbuvir 400 mg) schedule must be individualized by the physician in charge of treatment, and will vary according to the viral genotype that is being treated. Chronic hepatitis C is a serious infection of the liver which occurs following an infection with the hepatitis C virus. Upon reaching the cells of the liver, the virus begins to multiply, which it achieves by means of copying its DNA and RNA. A complete cure may even be possible. Ledviclear generic Harvoni (Ledipasvir 90 mg/sofosbuvir 400 mg) of Abbott is a breakthrough treatment for Hepatitis C infections. Ledviclear generic Harvoni (Ledipasvir 90 mg/sofosbuvir 400 mg) are film coated tablets each contain 400mg sofosbuvir and 90mg Ledipasvir.